Institutional Ownership Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE). We have compiled data on the 325 institutions that hold shares in the stock, with a total of 85.7 Million shares, which have been reported (via 13F filing form) to have a value of $3.87 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
755,683
shares
|
$35.1 Million
0.1% of portfolio
|
Q3 2024
Added 32.97%
|
|
|
First Light Asset Management, LLC
Edina, MN |
Nov 14, 2024 Q3 2024 |
755,102
shares
|
$35 Million
3.65% of portfolio
|
Q3 2024
Reduced 21.6%
|
|
|
Avidity Partners Management LP
Dallas, TX |
Nov 14, 2024 Q3 2024 |
752,000
shares
|
$34.9 Million
2.56% of portfolio
|
Q3 2024
Reduced 21.67%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
750,000
shares
|
$34.8 Million
3.16% of portfolio
|
Q3 2024
Reduced 58.33%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Nov 08, 2024 Q3 2024 |
724,182
shares
|
$33.6 Million
0.1% of portfolio
|
Q3 2024
Reduced 12.79%
|
|
|
Candriam S.C.A.
|
Nov 13, 2024 Q3 2024 |
713,092
shares
|
$33.1 Million
0.23% of portfolio
|
Q3 2024
Added 3.51%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
710,689
shares
|
$33 Million
0.02% of portfolio
|
Q3 2024
Reduced 61.6%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2024 Q3 2024 |
653,660
shares
|
$30.3 Million
0.1% of portfolio
|
Q3 2024
Added 21.1%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
633,715
shares
|
$29.4 Million
1.89% of portfolio
|
Q3 2024
Added 49.11%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
594,521
shares
|
$27.6 Million
0.01% of portfolio
|
Q3 2024
Added 10.58%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
582,976
shares
|
$27.1 Million
0.03% of portfolio
|
Q2 2023
Added 74.53%
|
|
|
Emerald Advisers, LLC
|
Oct 29, 2024 Q3 2024 |
569,798
shares
|
$26.4 Million
1.32% of portfolio
|
Q3 2024
Added 17.08%
|
|
|
Eagle Health Investments LP
Greenwich, CT |
Nov 12, 2024 Q3 2024 |
561,700
shares
|
$26.1 Million
5.92% of portfolio
|
Q3 2024
Added 7.09%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Nov 12, 2024 Q3 2024 |
542,373
shares
|
$25.2 Million
0.01% of portfolio
|
Q3 2024
Added 46.49%
|
|
|
Fred Alger Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
536,298
shares
|
$24.9 Million
0.15% of portfolio
|
Q3 2024
Reduced 2.3%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 12, 2024 Q3 2024 |
520,550
shares
|
$24.2 Million
0.03% of portfolio
|
Q3 2024
Reduced 6.51%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
506,510
shares
|
$23.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 19.54%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
473,324
shares
|
$22 Million
0.0% of portfolio
|
Q3 2024
Added 23.95%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
467,836
shares
|
$21.7 Million
0.0% of portfolio
|
Q3 2024
Reduced 6.05%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 07, 2024 Q3 2024 |
466,569
shares
|
$21.6 Million
0.22% of portfolio
|
Q3 2024
Added 14.77%
|
|
|
Emerald Mutual Fund Advisers Trust
|
Oct 29, 2024 Q3 2024 |
429,302
shares
|
$19.9 Million
1.35% of portfolio
|
Q3 2024
Added 9.93%
|
|
|
Axa S.A.
Paris, I0 |
Nov 14, 2024 Q3 2024 |
425,390
shares
|
$19.7 Million
0.07% of portfolio
|
Q3 2024
Added 0.01%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
400,833
shares
|
$18.6 Million
0.16% of portfolio
|
Q3 2024
Reduced 44.09%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
392,760
shares
|
$18.2 Million
0.01% of portfolio
|
Q3 2024
Added 92.32%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
329,733
shares
|
$15.3 Million
2.86% of portfolio
|
Q3 2024
Reduced 13.35%
|